TABLE 1.
Susceptibility to ciprofloxacin of N. gonorrhoeae strains isolated in Denmark from 1995 to 1998
| Yr | No. of strains testeda | No. (%) of strains with MICs (μg/ml) of CIPb:
|
MIC (μg/ml)c
|
||||
|---|---|---|---|---|---|---|---|
| ≤0.03 | 0.06–0.5 | ≥1 | 50% | 90% | Range | ||
| 1995 | 276 | 259 (93.1) | 8 (2.9) | 11 (3.9) | 0.004 | 0.016 | 0.002–16 |
| 1996 | 159 | 146 (91.8) | 4 (2.5) | 9 (5.7) | 0.004 | 0.016 | 0.002–8 |
| 1997 | 177 | 156 (88.1) | 11 (6.2) | 10 (5.6) | 0.004 | 0.128 | ≤0.001–32 |
| 1998 | 197 | 171 (86.8) | 14 (7.1) | 12 (6.1) | 0.004 | 0.128 | ≤0.001–16 |
a
One isolate per patient.
b
CIP, ciprofloxacin.
c
50% and 90%, MICs at which 50 and 90% of the isolates were inhibited, respectively.